Browse the evidence

Obesity in breast cancer patients is mediated by hormonal profiles that stimulate breast cancer growth, including higher estrogen, androgen, and insulin/IGF-1 levels.

Weight loss helps reduce breast cancer risk by lowering levels of growth-stimulating hormones like estrogen and insulin. This biological mechanism supports the clinical recommendation for weight management.

Consumption of peanut butter is only weakly associated with a reduced risk of coronary heart disease compared to whole nuts.

While whole nuts are strongly linked to heart health, peanut butter shows a much weaker association. This may be due to added hydrogenated fats in commercial brands. Choosing whole nuts or natural peanut butter without hydrogenated fats is likely more beneficial.

Among adults aged 50-71, higher coffee consumption (≥2 cups/day) is inversely associated with total mortality and mortality from heart disease, respiratory disease, stroke, injuries, diabetes, and infections, but not cancer, after adjusting for confounders like smoking.

If you drink coffee, continuing to drink 2 or more cups per day is associated with a lower risk of death from various causes, including heart disease and stroke, in this large study. The benefits appear to hold for both men and women, regardless of whether the coffee is caffeinated or decaffeinated. However, this is an association, not proof of causation, and individual tolerance to caffeine should still be considered.

Leptin administration effectively reverses hyperphagia and obesity in humans with congenital leptin deficiency, but has only modest and variable effects on body weight in obese individuals with normal or high leptin levels.

If you have been diagnosed with a rare genetic inability to produce leptin, leptin therapy is life-saving and effective. However, for the vast majority of people with common obesity, taking leptin supplements will not work because your body has developed resistance to the hormone. Focus on mechanisms that improve insulin sensitivity and metabolic health rather than seeking leptin as a direct weight-loss drug.

Pharmacological inhibition of the mTOR pathway using rapamycin extends lifespan in mice and is currently being tested in humans, though it carries metabolic side effects like insulin resistance.

Rapamycin extends mouse lifespan significantly but has side effects like insulin resistance. Human trials are currently underway to determine safe dosing for healthy older adults. Do not self-administer; wait for clinical trial results.

The Trp64Arg missense mutation in the beta3-adrenergic receptor gene is associated with an earlier onset of non-insulin-dependent diabetes mellitus (NIDDM) in Pima Indians, specifically in those homozygous for the mutation.

If you have the Trp64Arg mutation in your beta3-adrenergic receptor gene (particularly if you are homozygous), you are genetically predisposed to develop type 2 diabetes at a younger age. This is linked to a slightly lower resting metabolic rate. You should prioritize regular metabolic screening and focus on maintaining energy balance through diet and physical activity to counteract this genetic tendency, rather than assuming diabetes is inevitable.

In healthy young adults undergoing nutritional transition, a higher-fat diet (40% energy) compared to a lower-fat diet (20% energy) causes unfavorable shifts in gut microbiota (decreased Faecalibacterium/Blautia, increased Bacteroides/Alistipes), reduces short-chain fatty acids, and increases plasma proinflammatory markers.

If you are young and healthy but your diet is shifting towards higher fat intake, be aware that increasing fat to 40% of your calories (while keeping calories constant) may negatively impact your gut bacteria and increase inflammation markers like CRP. Switching to a lower fat diet (20% of calories) was associated with more favorable gut bacteria (higher Faecalibacterium and Blautia) and lower inflammation.

Individual differences in trait reward drive (BAS-drive) predict the magnitude of neural activation in the fronto-striatal-amygdala-midbrain network when viewing images of appetizing foods.

If you find yourself constantly distracted by food advertisements or packaging, it may not be a lack of willpower but a higher neural sensitivity to these cues. Recognizing this 'reward drive' trait can help you design your environment to minimize exposure to these triggers, rather than relying solely on mental discipline.

In healthy adult men, dietary alpha-linolenic acid (ALNA) is converted to eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA), but conversion to docosahexaenoic acid (DHA) is severely restricted or absent.

If you rely on plant sources like flaxseed or walnuts for your omega-3s, know that your body converts them to EPA and DPA, but barely makes DHA. To ensure adequate DHA levels, you likely need to consume pre-formed DHA from fish or algae, as your body cannot efficiently make it from plant fats alone.

Combined exercise and nutritional supplementation does not provide a clinically significant additional benefit to muscle mass, strength, or physical performance compared to exercise alone in older adults.

If you are over 60, focus on resistance training. You do not need to buy expensive protein powders, creatine, or amino acid supplements to see improvements in muscle mass, strength, or physical performance. Exercise alone is sufficient for the vast majority of older adults.

Rosiglitazone treatment induces mitochondrial biogenesis and remodeling in white adipose tissue, leading to increased fatty acid oxidation and oxygen consumption, which contributes to improved insulin sensitivity.

This research explains how rosiglitazone works at a cellular level in fat tissue: it boosts the number and efficiency of mitochondria, helping fat cells burn more fatty acids and oxygen. This metabolic shift improves how the body handles insulin. While the drug can cause slight weight gain by shifting fat storage to safer subcutaneous areas, its primary benefit is metabolic health improvement through enhanced fat oxidation.

Elevated plasma C-reactive protein (CRP) levels in men are critically correlated with abdominal adipose tissue accumulation (visceral fat) and total body fat mass, rather than plasma lipoprotein-lipid profiles.

If you are a man with high C-reactive protein (a marker of inflammation), your body fat distribution matters more than your cholesterol numbers. Specifically, reducing abdominal (visceral) fat is the most effective way to lower CRP levels. Focus on reducing belly fat through lifestyle changes, as this drives the inflammatory response more than lipid levels do.

The induction of FGF21 during protein restriction is mediated by the GCN2/eIF2α signaling pathway and requires PPARα.

This is a basic science mechanism. It explains that the body detects low amino acids via the GCN2 kinase, which then triggers FGF21 production. This pathway is conserved in humans, suggesting that amino acid sensing is key to metabolic regulation.

Targeting senescent cells (via genetic clearance or JAK1/2 inhibition) in aged individuals restores adipose tissue function, increases insulin sensitivity, and prevents age-related fat loss by suppressing the secretion of activin A.

This research suggests that age-related fat loss and insulin resistance are driven by 'zombie' (senescent) cells releasing harmful signals like activin A. In animal models, blocking these signals using a specific drug (ruxolitinib) preserved fat mass and improved metabolic health. While promising, this is currently an experimental application of an existing drug in animals, not a standard human therapy.

Senescent fat progenitors secrete activin A, which directly inhibits adipogenesis (fat cell formation) in non-senescent progenitors, contributing to age-related lipodystrophy.

This finding explains why fat tissue function declines with age: senescent cells release activin A, which blocks the creation of new, healthy fat cells. This is a biological mechanism, not a lifestyle factor.

Endoplasmic reticulum (ER) stress in adipose tissue, triggered by nutrient excess and obesity, activates inflammatory pathways (JNK, NFkB) that directly cause insulin resistance.

In obesity, fat cells become stressed, triggering an internal alarm (ER stress) that releases inflammatory signals blocking insulin. This explains why weight loss alone might not fully restore metabolic health if cellular stress persists. Interventions that reduce ER stress (like chemical chaperones in research) show promise in restoring insulin sensitivity.

Chemical chaperones (PBA and TUDCA) that alleviate ER stress improve glucose tolerance and insulin sensitivity in obese, insulin-resistant models without affecting body weight.

Research suggests that reducing cellular stress in fat cells using specific chemical chaperones (like PBA or TUDCA) can improve how the body handles sugar and insulin, even without weight loss. This highlights the importance of cellular health beyond just calories.

The biosynthesis of long-chain n-3 polyunsaturated fatty acids (EPA and DHA) from the plant-based precursor alpha-linolenic acid (ALA) is highly inefficient in healthy adults, with only about 0.2% of plasma ALA converting to EPA.

If you rely on plant sources like flax or walnuts for omega-3s, understand that your body converts very little of them into the active forms (EPA/DHA) your brain and heart need. To ensure adequate levels, incorporate direct sources of long-chain n-3 fatty acids, such as fatty fish or algae-based supplements, rather than relying solely on plant precursors.

Insulin resistance and obesity increase the secretory demand on beta-cells, which accelerates the formation of cytotoxic IAPP aggregates and amyloid deposition.

Managing insulin resistance through weight loss or exercise may reduce the 'secretory demand' on beta-cells, thereby slowing the accumulation of toxic amyloid proteins that destroy insulin-producing cells.

While endurance exercise normalizes most mitochondrial protein expression and ATP production capacity, it does not fully restore mitochondrial DNA (mtDNA) abundance or all nuclear transcription factors to young levels.

Even with decades of endurance training, some molecular markers of aging (like mtDNA copy number) may not fully revert to youthful levels. However, the functional output (ATP production) is largely preserved, suggesting functional compensation for these residual molecular deficits.

Resistant starch and nonstarch polysaccharides (NSPs) are not digested in the small intestine but are fermented by colon microbiota to produce short-chain fatty acids (SCFAs), contributing to health benefits.

Include sources of resistant starch (like cooled cooked potatoes or rice) and nonstarch polysaccharides (vegetables, whole grains) in your diet. These components are not fully digested in the small intestine but are fermented by gut bacteria to produce beneficial short-chain fatty acids, supporting colon health.

Anabolic steroids are performance enhancers, particularly in women, but carry a high risk of virilization despite attempts to dissociate anabolic and androgenic effects.

Anabolic steroids enhance performance, especially in women, but carry a high risk of virilization. Do not assume you are immune to side effects.

Obese individuals with high insulin sensitivity (Metabolically Healthy Obese, MHO) exhibit significantly lower levels of inflammatory markers, specifically C-reactive protein (CRP) and alpha-1 antitrypsin, compared to obese individuals with insulin resistance, suggesting that low-grade inflammation is a key differentiator of metabolic health in obesity.

For obese individuals, focusing solely on weight loss may miss critical metabolic health indicators. Assessing insulin sensitivity and inflammation (via CRP) is crucial, as some individuals with high body fat maintain low inflammation and high insulin sensitivity, protecting them from cardiovascular risk. This suggests that metabolic health is distinct from adiposity.

Estrogen suppresses food intake by acting on hypothalamic neurons (POMC, NPY) and reducing orexigenic signals like Neuropeptide Y (NPY) and Ghrelin.

Estrogen helps regulate your appetite by signaling to your brain to eat less. When estrogen drops, this signal weakens, potentially leading to increased hunger.